Neurostimulation Devices Market: By Stimulation System, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Percutaneous Electrical Nerve Stimulation, and Others), By Disease Indication, By Charging System, By End-User and Geography  

Neurostimulation Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Stimulation System (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation, Percutaneous Electrical Nerve Stimulation (PENS), and Others), By Disease Indication (Pain, Neurological Disorders, Sleep Apnea, Bladder and Bowel dysfunction and Others), By Charging System (Rechargeable and Non-rechargeable), By End-User (Hospitals, Specialty Clinics, and Others) and Region  

Neurostimulation Devices Market size was valued at US$ 5.47 billion in 2022.  It is expected to reach US$ 10.96 billion in 2029, at a CAGR of 11.8% from 2023-2029. For the treatment of chronic pain, movement problems, epilepsy, and Parkinson's disease, neurostimulation devices administer electrical stimulation to specific regions of the patient's brain, spinal cord, or peripheral nervous system. Spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and cortical stimulators are among the neurostimulation devices. High costs, device malfunctions, and stringent regulatory policies are projected to restrain the growth of the neurostimulation devices market over the forecast period. Furthermore, an increase in the incidence and prevalence of pain and neurological disorders is projected to drive the growth of the neurostimulation devices market. Increases in costs to manage pain conditions are creating a burden on the healthcare system. As per the estimates of the research article published in the Institute of Medicine (IOM) in 2011, the annual healthcare costs due to pain management is at least US$ 560-635 Bn annually in the U.S. In addition, the lack of side effects for the neuromodulation devices are fuelling the growth of the neurostimulation devices market.

Neurostimulation Devices Market Key Developments:

In February 2014, TGA gave hazard alerts to Medtronic's deep brain and spinal cord stimulation systems due to unexpected loss of stimulation and over-stimulation of the devices in Australia.  

Neurostimulation Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

11.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Neurostimulation Devices Market Dynamics

Rise in adoption of novel devices such as neurostimulation devices in the management of various diseases: pain, neurological disorders, obesity, and sleep apnea, among others over conventional drug treatments are projected to create significant opportunities for the neurostimulation device manufacturers. Currently, few ailments like parkinson's, epilepsy, and urinary incontinence conditions have limited treatment options. Hence, neurostimulation devices became an alternative treatment method to treat aforementioned conditions. 

Neurostimulation Devices Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2022

US$ 5.47 billion

Market Size in 2029

US$ 10.96 billion

Market CAGR

11.8%

By Stimulation

  • Spinal Cord Stimulation (SCS)
  • Deep Brain Stimulation (DBS)
  • Vagus Nerve Stimulation (VNS)
  • Sacral Nerve Stimulation (SNS)
  • Percutaneous Electrical Nerve Stimulation (PENS)
  • Others

By Disease Indication

  • Pain
  • Neurological Disorders (Includes parkinson's disease, epilepsy, depression, and movement related disorders)
  • Sleep Apnea
  • Bladder and Bowel dysfunction
  • Others

By Charging System

  • Rechargeable
  • Non- Rechargeable

By End User

  • Hospitals
  • Specialty Clinics
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

The neurostimulation devices market is projected to expand at a CAGR of 11.8% during the forecast period    

Abbott Laboratories, Axonics Modulation Technologies, BioControl Medica, Bioness Inc, Biowave Corporation

North America is the fastest-growing region for  The neurostimulation devices market  

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Neurostimulation Devices Market Introduction 
2.1.Global Neurostimulation Devices Market  - Taxonomy
2.2.Global Neurostimulation Devices Market  - Definitions
2.2.1. By Stimulation
2.2.2. By Disease Indication
2.2.3. By Charging System
2.2.4. By Region
3.Global Neurostimulation Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Neurostimulation Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Neurostimulation Devices Market  By Stimulation, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Spinal Cord Stimulation (SCS)
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Deep Brain Stimulation (DBS)
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Vagus Nerve Stimulation (VNS)
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Sacral Nerve Stimulation (SNS)
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Percutaneous Electrical Nerve Stimulation (PENS)
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Neurostimulation Devices Market  By Disease Indication, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Pain
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Neurological Disorders (Includes parkinson's disease, epilepsy, depression, and movement related disorders)
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Sleep Apnea
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Bladder and Bowel dysfunction
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Neurostimulation Devices Market  By Charging System, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Rechargeable
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Non- Rechargeable
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Neurostimulation Devices Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Neurostimulation Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Stimulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Spinal Cord Stimulation (SCS)
9.1.2.Deep Brain Stimulation (DBS)
9.1.3.Vagus Nerve Stimulation (VNS)
9.1.4.Sacral Nerve Stimulation (SNS)
9.1.5.Percutaneous Electrical Nerve Stimulation (PENS)
9.1.6.Others
9.2.  Disease Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Pain
9.2.2.Neurological Disorders (Includes parkinson's disease, epilepsy, depression, and movement related disorders)
9.2.3.Sleep Apnea
9.2.4.Bladder and Bowel dysfunction
9.2.5.Others
9.3.  Charging System Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Rechargeable
9.3.2.Non- Rechargeable
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Neurostimulation Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Stimulation Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Spinal Cord Stimulation (SCS)
10.1.2.Deep Brain Stimulation (DBS)
10.1.3.Vagus Nerve Stimulation (VNS)
10.1.4.Sacral Nerve Stimulation (SNS)
10.1.5.Percutaneous Electrical Nerve Stimulation (PENS)
10.1.6.Others
10.2.  Disease Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Pain
10.2.2.Neurological Disorders (Includes parkinson's disease, epilepsy, depression, and movement related disorders)
10.2.3.Sleep Apnea
10.2.4.Bladder and Bowel dysfunction
10.2.5.Others
10.3.  Charging System Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Rechargeable
10.3.2.Non- Rechargeable
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Neurostimulation Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Stimulation Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Spinal Cord Stimulation (SCS)
11.1.2.Deep Brain Stimulation (DBS)
11.1.3.Vagus Nerve Stimulation (VNS)
11.1.4.Sacral Nerve Stimulation (SNS)
11.1.5.Percutaneous Electrical Nerve Stimulation (PENS)
11.1.6.Others
11.2.  Disease Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Pain
11.2.2.Neurological Disorders (Includes parkinson's disease, epilepsy, depression, and movement related disorders)
11.2.3.Sleep Apnea
11.2.4.Bladder and Bowel dysfunction
11.2.5.Others
11.3.  Charging System Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Rechargeable
11.3.2.Non- Rechargeable
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Neurostimulation Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Stimulation Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Spinal Cord Stimulation (SCS)
12.1.2.Deep Brain Stimulation (DBS)
12.1.3.Vagus Nerve Stimulation (VNS)
12.1.4.Sacral Nerve Stimulation (SNS)
12.1.5.Percutaneous Electrical Nerve Stimulation (PENS)
12.1.6.Others
12.2.  Disease Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Pain
12.2.2.Neurological Disorders (Includes parkinson's disease, epilepsy, depression, and movement related disorders)
12.2.3.Sleep Apnea
12.2.4.Bladder and Bowel dysfunction
12.2.5.Others
12.3.  Charging System Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Rechargeable
12.3.2.Non- Rechargeable
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Neurostimulation Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Stimulation Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Spinal Cord Stimulation (SCS)
13.1.2.Deep Brain Stimulation (DBS)
13.1.3.Vagus Nerve Stimulation (VNS)
13.1.4.Sacral Nerve Stimulation (SNS)
13.1.5.Percutaneous Electrical Nerve Stimulation (PENS)
13.1.6.Others
13.2.  Disease Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Pain
13.2.2.Neurological Disorders (Includes parkinson's disease, epilepsy, depression, and movement related disorders)
13.2.3.Sleep Apnea
13.2.4.Bladder and Bowel dysfunction
13.2.5.Others
13.3.  Charging System Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Rechargeable
13.3.2.Non- Rechargeable
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories (U.S.)
14.2.2.Axonics Modulation Technologies, Inc., (U.S.)
14.2.3.BioControl Medical (U.S.)
14.2.4.Bioness Inc. (U.S.)
14.2.5.Biowave Corporation (U.S.)
14.2.6.Boston Scientific Corporation (U.S.)
14.2.7.Cefaly Technology (Belgium)
14.2.8.Cerbomed GmbH (Germany)
14.2.9.Cogentix Medical (U.S.)
14.2.10.CVRx (U.S.)
14.2.11.Enteromedics Inc. (U.S.)
14.2.12.Imthera (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Abbott Laboratories (U.S.)
  • Axonics Modulation Technologies, Inc., (U.S.)
  • BioControl Medical (U.S.)
  • Bioness Inc. (U.S.)
  • Biowave Corporation (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Cefaly Technology (Belgium)
  • Cerbomed GmbH (Germany)
  • Cogentix Medical (U.S.)
  • CVRx (U.S.)
  • Enteromedics Inc. (U.S.)
  • Imthera (U.S.)
  • Inspire Medical Systems Inc., (U.S.)
  • LivaNova PLC (U.K.)
  • Mainstay Medical International PLC (Republic of Ireland)
  • Medtronic (U.S.)
  • Neuromod Devices Ltd (Republic of Ireland)
  • Neuropace,Inc., (U.S.)
  • Nevro Corp (U.S.)
  • Novum Therapeutics, Inc. (U.S.)
  • Respicardia, Inc. (U.S.)
  • ScyFIX (U.S.)
  • Soterix Medical Inc (U.S.)
  • SPR Therapeutics (U.S.)
  • Stimwave LLC (U.S.)
  • Synapse Biomedical Inc. (U.S.)
  • Brainsway Ltd (Israel)
  • MMJ Labs (U.S.)
  • Neuronetics (U.S.)
  • Neuronix LTD (Israel)

Related Industry Reports